Enabling 95% Patient Adherence With Rapid Patient Data Analytics

With an increasing focus on patient-outcomes and benefits, pharma companies are leveraging patient-level information, such as Protected Health Information, to track the complete patient treatment journey and make informed clinical and commercial decisions.

Patient-level analytics has the potential to influence patient behavior, specifically therapy-adherence patterns. However, sophisticated means of data management are required by pharma companies to harness its true potential owing to the huge volumes of complex patient-level data across geographies. Companies that do not seize this opportunity, fail to improve outcomes for their patients and lose out to the competition.

Read this illustration to know how Axtria enabled rapid patient analytics for a global biotech company by streamlining fragmented patient-level data into a unified data hub, built on Axtria DataMAx^TM, in a HIPAA environment, enriched with advanced analytics algorithms for actionable patient-level insights.

The effort resulted in the following:

95% Patient Adherence

Helped in improving health outcomes due to higher adherence. The client received industry-wide recognition for this.

Weekly Insights

Reduced the data-to-insight time for the patient journey from once in six months to weekly. Ensured close tracking of drug performance and enabled prompt corrective actions.

Contact us at insights@axtria.com with any questions.